<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">Nature and Science of Sleep</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove Medical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25429246</article-id>
      <article-id pub-id-type="pmc">4242689</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S46818</article-id>
      <article-id pub-id-type="publisher-id">nss-6-137</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Innovative treatments for adults with obstructive sleep apnea</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Weaver</surname>
            <given-names>Terri E</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-6-137">1</xref>
          <xref ref-type="aff" rid="af2-nss-6-137">2</xref>
          <xref ref-type="corresp" rid="c1-nss-6-137"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Calik</surname>
            <given-names>Michael W</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-6-137">1</xref>
          <xref ref-type="aff" rid="af2-nss-6-137">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Farabi</surname>
            <given-names>Sarah S</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-6-137">1</xref>
          <xref ref-type="aff" rid="af2-nss-6-137">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fink</surname>
            <given-names>Anne M</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-6-137">1</xref>
          <xref ref-type="aff" rid="af2-nss-6-137">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Galang-Boquiren</surname>
            <given-names>Maria T</given-names>
          </name>
          <xref ref-type="aff" rid="af2-nss-6-137">2</xref>
          <xref ref-type="aff" rid="af3-nss-6-137">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kapella</surname>
            <given-names>Mary C</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-6-137">1</xref>
          <xref ref-type="aff" rid="af2-nss-6-137">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prasad</surname>
            <given-names>Bharati</given-names>
          </name>
          <xref ref-type="aff" rid="af2-nss-6-137">2</xref>
          <xref ref-type="aff" rid="af4-nss-6-137">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carley</surname>
            <given-names>David W</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-6-137">1</xref>
          <xref ref-type="aff" rid="af2-nss-6-137">2</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-nss-6-137"><label>1</label>Biobehavioral Health Science Department, College of Nursing, University of Illinois at Chicago, Chicago, IL, USA</aff>
      <aff id="af2-nss-6-137"><label>2</label>Center for Narcolepsy, Sleep and Health, University of Illinois at Chicago College of Nursing, Chicago, IL, USA</aff>
      <aff id="af3-nss-6-137"><label>3</label>Department of Orthodontics, University of Illinois at Chicago College of Dentistry, Chicago, IL, USA</aff>
      <aff id="af4-nss-6-137"><label>4</label>Sleep Center, Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago, IL, USA</aff>
      <author-notes>
        <corresp id="c1-nss-6-137">Correspondence: Terri E Weaver, University of Illinois at Chicago College of Nursing, 845 S Damen Ave MC 802, Chicago, IL 60612-7350, USA, Tel +1 708 771 5623, Fax +1 708 771 5673, Email <email>teweaver@uic.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <volume>6</volume>
      <fpage>137</fpage>
      <lpage>147</lpage>
      <permissions>
        <copyright-statement>© 2014 Weaver et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license>
          <license-p>The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p>
        </license>
      </permissions>
      <abstract>
        <p><citation_analysis attribute="positive">Obstructive sleep apnea (OSA) affects one in five adult males and is associated with significant comorbidity, cognitive impairment, excessive daytime sleepiness, and reduced quality of life. For over 25 years, the primary treatment has been continuous positive airway pressure, which introduces a column of air that serves as a pneumatic splint for the upper airway, preventing the airway collapse that is the physiologic definition of this syndrome. However, issues with patient tolerance and unacceptable levels of treatment adherence motivated the exploration of other potential treatments. With greater understanding of the physiologic mechanisms associated with OSA, novel interventions have emerged in the last 5 years. The purpose of this article is to describe new treatments for OSA and associated complex sleep apnea. New approaches to complex sleep apnea have included adaptive servoventilation. There is increased literature on the contribution of behavioral interventions to improve adherence with continuous positive airway pressure that have proven quite effective. New non-surgical treatments include oral pressure devices, improved mandibular advancement devices, nasal expiratory positive airway pressure, and newer approaches to positional therapy. Recent innovations in surgical interventions have included laser-assisted uvulopalatoplasty, radiofrequency ablation, palatal implants, and electrical stimulation of the upper airway muscles. No drugs have been approved to treat OSA, but potential drug therapies have centered on increasing ventilatory drive, altering the arousal threshold, modifying loop gain (a dimensionless value quantifying the stability of the ventilatory control system), or preventing airway collapse by affecting the surface tension. An emerging approach is the application of cannabinoids to increase upper airway tone.</citation_analysis></p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>obstructive sleep apnea</kwd>
        <kwd>innovative treatment</kwd>
        <kwd>continuous positive airway pressure</kwd>
        <kwd>oral appliance</kwd>
        <kwd>nerve stimulation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Obstructive sleep apnea (OSA) is a common problem. The second most diagnosed respiratory condition after asthma, 9%–28% of women and 24%–26% of males in the US population have apneic events at a treatable level, making this syndrome a serious public health issue.</citation_analysis><citation_analysis attribute="positive"><xref rid="b1-nss-6-137" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> Untreated OSA has a profound effect on health and behavior, resulting in excessive daytime sleepiness, impaired cognition and mentation, decreased daytime function, and alterations in mood.</citation_analysis><citation_analysis attribute="positive"><xref rid="b1-nss-6-137" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="positive"> OSA contributes to increased heart disease, stroke, hypertension, diabetes, and obesity, with a high rate of comorbidity. The economic burden of untreated OSA is enormous, having a cost similar in magnitude to diabetes, ie, 132 billion dollars in 2002, with an estimated $15.9 billion for the 800,000 crashes attributed to OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="b2-nss-6-137" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b3-nss-6-137" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="positive"> From the perspective of the health care system, for each quality-adjusted life year, $3,354 and $11.1 billion in collision costs would be saved with successful continuous positive airway pressure (CPAP) treatment, the primary intervention for OSA for over 25 years.</citation_analysis><citation_analysis attribute="positive"><xref rid="b3-nss-6-137" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="positive"> CPAP introduces a column of air that serves as a pneumatic splint for the upper airway, preventing the airway collapse that is the physiologic definition of this syndrome. Despite demonstrated efficacy and potential cost savings, the overall effectiveness of CPAP is significantly limited by poor adherence.</citation_analysis><citation_analysis attribute="positive"><xref rid="b4-nss-6-137" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="negative"> This limitation has prompted the development of new approaches to produce more tolerable designs for CPAP treatment, approaches to enhance adherence, and innovations in other interventions to treat OSA. With greater understanding of the physiologic mechanisms associated with OSA, novel interventions have emerged in the last 5 years. The purpose of this article is to describe new treatments for OSA and associated complex sleep apnea.</citation_analysis></p>
    </sec>
    <sec>
      <title>Advances in positive airway pressure treatment</title>
      <p><citation_analysis attribute="positive">Complex sleep apnea refers to a pattern of sleep-disordered breathing that includes both obstructive apneas/hypopneas and central apneas. Specifically, this occurs in patients without daytime hypercapnia. Central apneas are noted during non-rapid eye movement sleep and may “emerge” during CPAP titration. It is likely that these individuals have a high loop gain (a dimensionless value quantifying the stability of the ventilatory control system) in addition to a collapsible airway. Loop gain is measured by repeatedly dropping CPAP pressure during sleep to induce prolonged hypopneas, and then returning CPAP pressure to normal. The return of normal pressure causes an overshoot of ventilation, called the “response”. Loop gain is calculated by dividing “the response” by “the stimulus” (the difference between ventilation during the hypopnea and zero ventilation). A high loop gain approaching a value of 1 reflects relative instability in the ventilatory system and predisposes to recurrent apneas. Adaptive servoventilators are spontaneous-timed bilevel positive airway pressure devices that estimate the patient’s minute ventilation and tidal volume and/or flow, and respond to it by delivering variable pressure support. Theoretically, this minimizes the hyperpneic phase (which precipitates central apneas). These devices provide better control of complex sleep apnea than other CPAP devices, particularly in patients with heart failure.</citation_analysis><citation_analysis attribute="positive"><xref rid="b6-nss-6-137" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b8-nss-6-137" ref-type="bibr">8</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">The S9™ (ResMed Ltd, Bella Vista, Australia) is a novel CPAP device that includes a humidification system with a heated tube, reduced noise levels, and an adaptive positive airway pressure algorithm. Use of the S9 device resulted in longer average CPAP use by approximately 30 minutes after 28 days in 50 patients with established CPAP use.</citation_analysis><citation_analysis attribute="positive"><xref rid="b9-nss-6-137" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> A new CPAP modality, SensAwake</citation_analysis><citation_analysis attribute="positive"><sup>®</sup></citation_analysis><citation_analysis attribute="neither"> (Fisher and Paykel Healthcare Ltd, Auckland, New Zealand), was developed to monitor breathing patterns and reduce pressure with awakenings. When tested in a group of 42 CPAP-naïve patients with OSA, the SensAwake modality had results similar to those of traditional CPAP.</citation_analysis><citation_analysis attribute="positive"><xref rid="b10-nss-6-137" ref-type="bibr">10</xref></citation_analysis></p>
    </sec>
    <sec>
      <title>Interventions to promote CPAP adherence</title>
      <p><citation_analysis attribute="positive">Adherence is the major obstacle to effective CPAP treatment. A Cochrane Collaboration report reviewing 30 studies of educational, supportive, and behavioral interventions concluded that all three types of interventions had a positive impact on CPAP usage in 2,047 adults with OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="b11-nss-6-137" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="positive"> There was moderate-quality evidence to support a modest increase in adherence to CPAP using short-term educational interventions and low-quality evidence to support a large increase in CPAP adherence using behavioral interventions such as cognitive behavioral therapy and motivational interviewing. Recently, Bartlett et al conducted a randomized controlled study comparing a group cognitive behavioral therapy intervention with a social interaction control on CPAP adherence.</citation_analysis><citation_analysis attribute="positive"><xref rid="b12-nss-6-137" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="positive"> They found no difference between groups in CPAP adherence or self-efficacy using CPAP at 1 or 6 months. In another randomized controlled study, Deng et al compared a stage-matched intervention with usual care in newly diagnosed OSA patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="b13-nss-6-137" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="positive"> Participants in the intervention group received care based on their stage of behavior change. Interventions ranged from education about OSA (stage 1) to setting and attaining goals for increased CPAP use at night (stage 4). They found significant differences between groups with regard to CPAP adherence at 1 and 3 months, and in the percentage of subjects using CPAP for more than 4 hours per night.</citation_analysis><citation_analysis attribute="positive"><xref rid="b13-nss-6-137" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="positive"> Sawyer et al tested a risk screening questionnaire, ie, the Index for Nonadherence to PAP, for CPAP nonadherence in a longitudinal study that included 97 subjects with newly diagnosed OSA. The final Index for Nonadherence to PAP model included 19 items with questions regarding health literacy, self-efficacy, body mass index (BMI), marriage status, presenting symptoms, and gender. The questionnaire successfully identified CPAP nonadherers and may provide a tool for early intervention development to decrease or prevent nonadherence.</citation_analysis><citation_analysis attribute="positive"><xref rid="b14-nss-6-137" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="positive"> Although there is growing evidence to support educational and behavioral interventions to enhance adherence with CPAP, further studies with stronger designs and larger samples are needed.</citation_analysis></p>
    </sec>
    <sec>
      <title>Nasal expiratory positive airway pressure</title>
      <p><citation_analysis attribute="positive">During the five distinct phases of the respiratory cycle, the final expiratory phase has the greatest risk of airway occlusion. At the end of expiration, there is neither positive pressure nor inspiratory phasic activation of the upper airway dilator muscles.</citation_analysis><citation_analysis attribute="positive"><xref rid="b15-nss-6-137" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="positive"> Moreover, there is significant narrowing of the upper airway during expiration preceding apnea,</citation_analysis><citation_analysis attribute="positive"><xref rid="b16-nss-6-137" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither"> and the lowest cross-sectional of the upper airway occurs during expiration.</citation_analysis><citation_analysis attribute="positive"><xref rid="b17-nss-6-137" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b19-nss-6-137" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="positive"> The nasal expiratory positive airway pressure (nEPAP) device allows for low inspiratory resistance while increasing expiratory resistance to prevent upper airway collapse (see </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f1-nss-6-137">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><xref rid="b18-nss-6-137" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b19-nss-6-137" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither"> It comprises a single-use device containing a mechanical valve that can create high expiratory resistance, with very low inspiratory resistance applied to each nostril with an adhesive to provide a seal.</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b21-nss-6-137" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="positive"> There have been six clinical trials using nEPAP.</citation_analysis><citation_analysis attribute="positive"><xref rid="b18-nss-6-137" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b24-nss-6-137" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="positive"> In all studies, there was a significant decrease in apnea-hypopnea index (AHI). Four of the nEPAP studies were uncontrolled, proof-of-concept studies,</citation_analysis><citation_analysis attribute="positive"><xref rid="b18-nss-6-137" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b23-nss-6-137" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b24-nss-6-137" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> one was a prospective, sham-controlled, randomized, double-blind, multicenter clinical trial,</citation_analysis><citation_analysis attribute="positive"><xref rid="b21-nss-6-137" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither"> and another was an extension of the latter clinical trial to observe long-term treatment durability and safety.</citation_analysis><citation_analysis attribute="positive"><xref rid="b22-nss-6-137" ref-type="bibr">22</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In the proof-of-concept studies, two used nEPAP devices of varying expiratory resistances to increase tolerability.</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b24-nss-6-137" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> In these proof-of-concept studies, there was a 31%–49% decrease in AHI.</citation_analysis><citation_analysis attribute="positive"><xref rid="b18-nss-6-137" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b23-nss-6-137" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b24-nss-6-137" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> Two studies showed no difference in sleep architecture,</citation_analysis><citation_analysis attribute="positive"><xref rid="b18-nss-6-137" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="positive"> and one study showed significant changes in sleep architecture.</citation_analysis><citation_analysis attribute="positive"><xref rid="b24-nss-6-137" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="positive"> Two studies quantified and showed significant improvements in daytime sleepiness or sleep quality,</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b24-nss-6-137" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="positive"> and three studies quantified and showed significant improvement in oxygen saturation.</citation_analysis><citation_analysis attribute="positive"><xref rid="b8-nss-6-137" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b24-nss-6-137" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> The results of the proof-of-concept trials are encouraging. However, as with CPAP,</citation_analysis><citation_analysis attribute="positive"><xref rid="b25-nss-6-137" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> tolerability and adherence to nEPAP was an issue. Although self-reported use was as high as 94%,</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b24-nss-6-137" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> 15% of participants in one study failed to take the device home.</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="negative"> In another study, there was a dropout rate of 22% due to lack of tolerability of nEPAP, and many adverse events like difficulty breathing and sleeping, dry mouth, and nasal discomfort were reported.</citation_analysis><citation_analysis attribute="positive"><xref rid="b24-nss-6-137" ref-type="bibr">24</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">A prospective, sham-controlled, double-blind, multicenter clinical trial randomized newly diagnosed or previously diagnosed but untreated OSA patients to either nEPAP or a sham group.</citation_analysis><citation_analysis attribute="positive"><xref rid="b21-nss-6-137" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="positive"> The sham treatment device was similar to the nEPAP device, with the only difference being that the sham device contained valves that did not provide expiratory resistance. The participants wore the nEPAP/sham devices for 3 months with two nonconsecutive night sleep studies a week into the study and two nonconsecutive night sleep studies at the end of the 3 month study period. The two nonconsecutive night sleep studies were done to evaluate on-device and off-device polysomnographs (randomly assigned). Significant median decreases in AHI after 1 week and 3 months of nEPAP were 53% and 43%, respectively, when compared with sham. There were also significant decreases in oxygen desaturation index, Epworth Sleepiness Scale, and arousal index, and significant changes in sleep architecture between the nEPAP and sham groups. Adherence was high in both the nEPAP and sham groups; however, there was significantly less adherence in the nEPAP group than in the sham group (88.2% versus 92.3%). Adverse events, like difficulty exhaling, nasal discomfort, dry mouth, headache, and insomnia, were not significantly different between the two groups; however, more participants dropped out of the nEPAP group due to adverse events. A follow-up study evaluated the long-term durability of treatment response and safety of nEPAP.</citation_analysis><citation_analysis attribute="positive"><xref rid="b22-nss-6-137" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="positive"> The positive results obtained from the original 3-month study</citation_analysis><citation_analysis attribute="positive"><xref rid="b21-nss-6-137" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither"> were replicated after 12 months of wearing nEPAP.</citation_analysis><citation_analysis attribute="positive"><xref rid="b22-nss-6-137" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither"> As in the 3-month study, adverse events were still reported.</citation_analysis><citation_analysis attribute="positive"><xref rid="b21-nss-6-137" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b22-nss-6-137" ref-type="bibr">22</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Although AHI is an important metric to quantify improvements in treatment response, another outcome that is important to the user as well as his or her sleeping partner is that of snoring. In three studies, the percentage of total sleep time spent snoring decreased significantly by 57.8%–74.4% with use of nEPAP, providing a quieter environment for the sleeping partner.</citation_analysis><citation_analysis attribute="positive"><xref rid="b18-nss-6-137" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-6-137" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b22-nss-6-137" ref-type="bibr">22</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">The significant improvements in AHI, oxygen saturation, and snoring with nEPAP are very encouraging, and the improvement in snoring suggests that this treatment may be suitable for those with mild OSA. Moreover, given the challenges of traveling with a CPAP device, nEPAP may be an alternative for patients who travel frequently. As with CPAP, adherence and tolerability are an issue. However, considering the ease of application, compact design, low cost, and availability of these devices (ie, accessible without a prescription), nEPAP may become a second-line therapy to CPAP.</citation_analysis></p>
    </sec>
    <sec>
      <title>Oral pressure therapy</title>
      <p><citation_analysis attribute="neither">Oral pressure therapy, in which a vacuum is applied to the oropharynx to pull the soft palate forward and stabilize the tongue, has recently been studied in adult patients with OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="b26-nss-6-137" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither"> The system, such as the Winx device (see </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f2-nss-6-137">Figure 2</xref></citation_analysis><citation_analysis attribute="positive">), includes a mouthpiece in a number of sizes, a vacuum pump, a console, and tubing. While breathing normally through the nose, continuous negative pressure in the oral cavity moves the soft palate forward into contact with the tongue to reduce obstruction. The negative pressure is isolated from the nasopharyngeal airway by the natural seal that occurs between the soft palate and tongue. In a multicenter, prospective, randomized, crossover trial, Colrain et al evaluated the safety and efficacy of an oral pressure therapy system in subjects with mild to severe OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="b27-nss-6-137" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="positive"> The therapy was well tolerated and used on average for 6 hours at night. Oral pressure therapy was associated with clinically significant improvements in AHI, sleep quality and continuity, and daytime sleepiness.</citation_analysis><citation_analysis attribute="positive"><xref rid="b27-nss-6-137" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="positive"> Although there is preliminary evidence to support oral pressure therapy as a therapy for OSA, additional studies with strong designs and larger samples are needed.</citation_analysis></p>
    </sec>
    <sec>
      <title>Oral appliance innovations</title>
      <p><citation_analysis attribute="neither">Although not a new concept, novel oral appliances, such as tongue repositioning or restraining devices, have recently been tested in people with OSA. A tongue-stabilizing device that uses suction to protrude the tongue was compared with a mandibular advancement device in a randomized crossover study of a small sample of patients recruited from a tertiary hospital sleep clinic.</citation_analysis><citation_analysis attribute="positive"><xref rid="b28-nss-6-137" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither"> Although the AHI was significantly improved with both the mandibular advancement device and the tongue-stabilizing device, compliance was poor for the tongue-stabilizing device, with participants preferring the mandibular advancement device. A full breath solution appliance was examined in adults diagnosed with OSA. This is an oral appliance that has a horizontal transpalatal bar with a vertical extension called the posterior tongue restrainer. The transpalatal bar and tissue make contact above the tongue and below the palatal mucosa when the person is supine during sleep, theoretically restraining and inhibiting the tongue from obstructing the upper airway. In this preliminary study, the mean AHI fell by 73% and the mean SaO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither"> significantly improved.</citation_analysis><citation_analysis attribute="positive"><xref rid="b29-nss-6-137" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="positive"> Dort and Remmers tested a combined approach using a mandibular repositioning appliance with an attached tongue-retaining device; the desired response (respiratory disturbance index &lt;10 events per hour) was achieved in 34% of subjects, but many subjects (39%) were nonresponders.</citation_analysis><citation_analysis attribute="positive"><xref rid="b30-nss-6-137" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="neither"> The authors concluded that patients require several weeks to acclimate to the device and achieve an optimal response, which may explain the poor response rate in this study.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Ngiam and Kyung investigated a novel mandibular advancement device that involved mini-implants and a facemask as anchors.</citation_analysis><citation_analysis attribute="positive"><xref rid="b31-nss-6-137" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="positive"> This device may be particularly beneficial in cases where there are too few teeth to retain the oral appliances, or in patients who cannot tolerate a bulky intraoral device. Albeit based on only ten subjects, the results showed a significant reduction in AHI and snoring frequency, although design alterations in the face pads were necessary to avoid pressure sores. Almeida et al showed how short-term oral appliances could be a viable treatment option in patients who are adherent to CPAP but need to pause use of the machine in certain circumstances, such as traveling or lack of power supply.</citation_analysis><citation_analysis attribute="positive"><xref rid="b32-nss-6-137" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither"> Having both treatment options provided good outcomes and more convenience for the patients.</citation_analysis></p>
      <p><citation_analysis attribute="positive">One factor enhancing the effectiveness of mandibular advancement device treatment is the ability to titrate the appliance to a patient’s specific needs. Titration protocols may be based on subjective parameters including patient comfort, objective parameters such as polysomnographic data, or both. To date, no consensus has been reached on a standardized titration protocol.</citation_analysis><citation_analysis attribute="positive"><xref rid="b33-nss-6-137" ref-type="bibr">33</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">In order to measure the overall therapeutic effectiveness of an oral appliance completely, objective compliance data must be obtained. To date, most relevant studies have relied on self-reporting. A thermosensor embedded in an oral appliance has been reported to have a high correlation with corresponding subjective reporting.</citation_analysis><citation_analysis attribute="positive"><xref rid="b34-nss-6-137" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="neither"> This same method was studied long term, and after 1 year the correlation remained the same with respect to self-report.</citation_analysis><citation_analysis attribute="positive"><xref rid="b35-nss-6-137" ref-type="bibr">35</xref></citation_analysis><citation_analysis attribute="positive"> Although not currently in widespread clinical use, this provides a safe and effective method for obtaining objective reports on patient adherence. Further studies need to be conducted to determine the optimal battery life, power consumption, and storage capacity of such compliance trackers. Recently, Smith and Verrett investigated a novel device that included a supplementary sensor to enable conservation of power and memory.</citation_analysis><citation_analysis attribute="positive"><xref rid="b36-nss-6-137" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="positive"> Their study also found a high correlation between subjective compliance reporting and data from their objective monitor. Objective compliance monitoring will be very valuable for long-term studies of oral appliance efficacy as well as interpreting outcomes of treatment.</citation_analysis></p>
    </sec>
    <sec>
      <title>Prediction of oral appliance treatment outcomes</title>
      <p><citation_analysis attribute="neither">Although oral appliance use for treating OSA has been studied extensively, it remains difficult to predict which patients will respond favorably to treatment with an oral appliance.</citation_analysis><citation_analysis attribute="positive"><xref rid="b37-nss-6-137" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, there is a need for prospective long-term studies to evaluate success rates.</citation_analysis><citation_analysis attribute="positive"><xref rid="b37-nss-6-137" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither"> Oropharyngeal crowding and obesity were studied as predictive factors for response to oral appliance therapy. Patients with moderate OSA who have oropharyngeal crowding, identified via Mallampati scoring, and who are obese were identified as poor responders to oral appliance therapy.</citation_analysis><citation_analysis attribute="positive"><xref rid="b38-nss-6-137" ref-type="bibr">38</xref></citation_analysis><citation_analysis attribute="positive"> Additional research has been conducted on craniofacial morphologic features as predictors for oral appliance treatment. Cephalometric measurements such as increase in mandibular plane to cranial base angle are related to poor response to oral appliance treatment, whereas shorter soft palate length, increased cranial base angulation, minimal retroglossal airway, short anterior face height, and mandibular retrusion have been related to successful oral appliance treatment. These findings support the view that successful oral appliance treatment is moderated by multiple anatomic factors.</citation_analysis><citation_analysis attribute="positive"><xref rid="b39-nss-6-137" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b40-nss-6-137" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="positive"> As dental professionals transition to three-dimensional imaging, further studies may be done utilizing three-dimensional landmarks and measurements to provide more accurate predictors of the outcome of oral appliance treatment. Recent studies utilizing magnetic resonance imaging, computed tomography, and cone-beam computed tomography have all provided valuable airway volumetric data that are not provided by two-dimensional cephalograms alone.</citation_analysis><citation_analysis attribute="positive"><xref rid="b41-nss-6-137" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b43-nss-6-137" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="positive"> Future research using volumetric airway imaging may provide valuable insights into predicting individual responses to oral appliance therapy.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Another method that can evaluate lateral airway dimensions aside from anteroposterior ones is nasal endoscopy. This method is promising as it is able to evaluate dynamic airway changes with an oral appliance either during sleep or wakefulness.</citation_analysis><citation_analysis attribute="positive"><xref rid="b44-nss-6-137" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b45-nss-6-137" ref-type="bibr">45</xref></citation_analysis><citation_analysis attribute="positive"> In 2014, Sasao et al evaluated a number of patients diagnosed with sleep apnea and subjected them to a nasoendoscopic procedure while advancing the mandible. His group proposed conducting this test during wakefulness due to its clinical practicality compared with performing it overnight during sleep. They found that the orohypopharynx widened in all patients but the velopharynx only widened in approximately 75% of subjects, and that after oral appliance treatment, the AHI scores of those without velopharyngeal widening did not decrease significantly. The use of nasoendoscopy with mandibular advancement may be valuable in the future to evaluate velopharynx widening as a predictor of the efficacy of treatment with an oral appliance.</citation_analysis><citation_analysis attribute="positive"><xref rid="b45-nss-6-137" ref-type="bibr">45</xref></citation_analysis></p>
    </sec>
    <sec>
      <title>Positional therapy</title>
      <p><citation_analysis attribute="neither">Sleep apnea in over half of patients with OSA is position- dependent,</citation_analysis><citation_analysis attribute="positive"><xref rid="b46-nss-6-137" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither"> defined as having at least double the AHI in the supine position compared with the lateral position.</citation_analysis><citation_analysis attribute="positive"><xref rid="b47-nss-6-137" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="positive"> Studies of the effect of positional therapy on OSA have shown positive results, ie, lower efficacy than CPAP, but often with better adherence, despite being potentially uncomfortable.</citation_analysis><citation_analysis attribute="positive"><xref rid="b48-nss-6-137" ref-type="bibr">48</xref></citation_analysis><citation_analysis attribute="neither"> Recent studies examining the efficacy of position therapy based on position monitoring with a supine alarm</citation_analysis><citation_analysis attribute="positive"><xref rid="b49-nss-6-137" ref-type="bibr">49</xref></citation_analysis><citation_analysis attribute="neither"> and a sleep position trainer device worn around the chest</citation_analysis><citation_analysis attribute="positive"><xref rid="b50-nss-6-137" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="neither"> showed that these new devices were well tolerated and markedly reduced supine sleeping time and AHI. Additional studies of improved positional therapy devices are indicated.</citation_analysis></p>
    </sec>
    <sec>
      <title>Surgical treatment approaches</title>
      <p><citation_analysis attribute="positive">Upper airway, facial skeletal, and bariatric surgeries for morbid obesity continue to offer important alternative treatment options for adult OSA. Surgical treatments may be selected based on patient preference and ability to tolerate or adhere to CPAP. Upper airway evaluation with a clinical staging system or dynamically with endoscopy during sleep/sedation, and with technologies such as cine magnetic resonance imaging, offer ways to localize upper airway anatomic compromise and tailor treatment to individual patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="b51-nss-6-137" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="neither"> Nasal surgery (eg, septoplasty, turbinectomy) can improve tolerability of CPAP therapy in selected patients with OSA and reduce snoring. Minimally invasive surgeries such as palatal implants and radiofrequency or laser-assisted uvulopalatopharyngoplasty are not efficacious in adult OSA and may be considered for primary snoring.</citation_analysis><citation_analysis attribute="positive"><xref rid="b52-nss-6-137" ref-type="bibr">52</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Many adults do not respond to single operative interventions and benefit from planned multilevel upper airway surgical modification either simultaneously or in staged protocols.</citation_analysis><citation_analysis attribute="positive"><xref rid="b53-nss-6-137" ref-type="bibr">53</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b54-nss-6-137" ref-type="bibr">54</xref></citation_analysis><citation_analysis attribute="positive"> A common staged protocol involves utilizing uvulopalatopharyngoplasty with tongue suspension or with genioglossus advancement and hyoid myotomy (Phase I)</citation_analysis><citation_analysis attribute="positive"><xref rid="b55-nss-6-137" ref-type="bibr">55</xref></citation_analysis><citation_analysis attribute="neither"> and maxillary and mandibular advancement osteotomy (Phase II). Several new techniques of upper airway surgical modifications have recently been described. Submucosal lingualplasty in combination with palatal surgery was found to be effective in improving symptoms and AHI in a case series of OSA patients with macroglossia.</citation_analysis><citation_analysis attribute="positive"><xref rid="b56-nss-6-137" ref-type="bibr">56</xref></citation_analysis><citation_analysis attribute="positive"> A transcervical technique to access the retrolingual space and perform radiofrequency ablation of hypertrophic lingual tonsils under sedation and local anesthesia has been reported and its effectiveness remains to be established.</citation_analysis><citation_analysis attribute="positive"><xref rid="b57-nss-6-137" ref-type="bibr">57</xref></citation_analysis><citation_analysis attribute="neither"> Other newly developed surgical approaches include modified uvulopalatopharyngoplasty and coblation channeling of the tongue, a coblation-assisted Lewis and MacKay operation, and transpalatal advancement.</citation_analysis><citation_analysis attribute="positive"><xref rid="b58-nss-6-137" ref-type="bibr">58</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b59-nss-6-137" ref-type="bibr">59</xref></citation_analysis><citation_analysis attribute="neither"> An investigational technique, typically used within a staged surgical approach, is transoral robotic surgery for tongue base reduction.</citation_analysis><citation_analysis attribute="positive"><xref rid="b60-nss-6-137" ref-type="bibr">60</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Mandibular advancement osteotomy results in a permanent increase in volume and reduction in length of the upper airway, and the extent of the anterior movements of the maxilla, soft palate, and hyoid are correlated with improvement in AHI.</citation_analysis><citation_analysis attribute="positive"><xref rid="b61-nss-6-137" ref-type="bibr">61</xref></citation_analysis><citation_analysis attribute="neither"> The predictability of post-surgical airway change can be improved with virtual surgical planning, a technique that combines computed tomography imaging with software reconstruction and surgical expertise.</citation_analysis><citation_analysis attribute="positive"><xref rid="b62-nss-6-137" ref-type="bibr">62</xref></citation_analysis><citation_analysis attribute="positive"> Notwithstanding effects on AHI and symptoms, upper airway soft tissue and skeletal surgical interventions may improve quality of life, driving performance, and mortality rates in appropriately selected adults with OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="b63-nss-6-137" ref-type="bibr">63</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b66-nss-6-137" ref-type="bibr">66</xref></citation_analysis></p>
    </sec>
    <sec>
      <title>Electrical stimulation</title>
      <p><citation_analysis attribute="positive">Remmers et al first suggested in 1978 that pharyngeal obstruction was related to loss of genioglossus muscle activity in OSA patients during sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="b67-nss-6-137" ref-type="bibr">67</xref></citation_analysis><citation_analysis attribute="neither"> Since then, several experimental methods to treat OSA have focused on electrically stimulating upper airway muscle activity directly by transcutaneous, intraoral, or intramuscular electrodes (see </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f3-nss-6-137">Figure 3</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><xref rid="b68-nss-6-137" ref-type="bibr">68</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b72-nss-6-137" ref-type="bibr">72</xref></citation_analysis><citation_analysis attribute="neither"> Although these methods decreased the severity of OSA, they also had the unfortunate consequence of induced arousals and concomitant sleep fragmentation related to the electrical stimuli.</citation_analysis></p>
      <p><citation_analysis attribute="negative">A more promising method of stimulating upper airway muscles to treat OSA, which emerged over a decade ago but stalled due to lack of reliable devices,</citation_analysis><citation_analysis attribute="positive"><xref rid="b73-nss-6-137" ref-type="bibr">73</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b76-nss-6-137" ref-type="bibr">76</xref></citation_analysis><citation_analysis attribute="neither"> is hypoglossal nerve stimulation (HNS).</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b81-nss-6-137" ref-type="bibr">81</xref></citation_analysis><citation_analysis attribute="neither"> In HNS, a silicone cuff with stimulating electrodes is surgically placed around a unilateral hypoglossal nerve, which includes motor neurons innervating both protrusor and retractor muscles of the tongue. Appropriate placement of the electrode cuff for activation of the protrusor muscles is confirmed by observing tongue protrusion during stimulation and by electromyographic monitoring during surgery. Stimulating leads are tunneled subplatysmally via the neck to the neurostimulator, which is placed subcutaneously inferior to the clavicle. From the neurostimulator, sensory leads are tunneled subcutaneously to intercostal muscles to monitor respiration.</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b81-nss-6-137" ref-type="bibr">81</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">The neurostimulator delivers either synchronous</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="neither"> or continuous stimulation.</citation_analysis><citation_analysis attribute="positive"><xref rid="b81-nss-6-137" ref-type="bibr">81</xref></citation_analysis><citation_analysis attribute="neither"> In synchronous stimulation, sensory leads detect inspiratory efforts that are analyzed by the neurostimulator. The neurostimulator’s software algorithm predicts the onset of inspiratory effort, delivering stimulation pulses between the end of the expiratory effort and the beginning of the next expiratory phase of each respiratory cycle. Synchronous stimulation systems depolarize the entire hypoglossal nerve during inspiratory effort, causing bulk tongue protrusion.</citation_analysis><citation_analysis attribute="positive"><xref rid="b76-nss-6-137" ref-type="bibr">76</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="neither"> In continuous stimulation, electrodes placed around the hypoglossal nerve are continuously and sequentially cycled from one electrode to the next in a predetermined fashion during the entire respiratory cycle. The focus of continuous stimulation is to increase tonic, rather than phasic, activation of the genioglossus.</citation_analysis><citation_analysis attribute="positive"><xref rid="b76-nss-6-137" ref-type="bibr">76</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b81-nss-6-137" ref-type="bibr">81</xref></citation_analysis><citation_analysis attribute="neither"> In both systems, stimulation periods are maintained on a duty cycle of &lt;50% to prevent neuromuscular fatigue of the tongue.</citation_analysis><citation_analysis attribute="positive"><xref rid="b76-nss-6-137" ref-type="bibr">76</xref></citation_analysis><citation_analysis attribute="neither"> After patients are implanted, stimulus titration for the patient occurs by gradually adjusting stimulus intensity (mA), frequency (Hz), and pulse width (μsec) to tolerable levels that consistently abolish inspiratory flow restriction during sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="b76-nss-6-137" ref-type="bibr">76</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Five recent HNS trials had similar inclusion and exclusion criteria. Two trials included participants with moderate to severe OSA (pretreatment AHI of 20–100) and BMI ≤40 and two trials included those with an AHI of 20–50 and BMI ≤32.</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="positive"> One trial included subjects with AHI ≥20 and BMI between 25 and 40.</citation_analysis><citation_analysis attribute="positive"><xref rid="b81-nss-6-137" ref-type="bibr">81</xref></citation_analysis><citation_analysis attribute="neither"> The upper threshold of BMI was necessary because previous investigations showed that HNS had no therapeutic effect in individuals with elevated BMI.</citation_analysis><citation_analysis attribute="positive"><xref rid="b78-nss-6-137" ref-type="bibr">78</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="positive"> Exclusion criteria were similar in all trials, and included prior surgery of the head or neck, pronounced anatomic abnormalities preventing effective use of HNS, ≥5% of central or mixed apneas, cardiovascular disease, and sleep disorders other than OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b81-nss-6-137" ref-type="bibr">81</xref></citation_analysis><citation_analysis attribute="positive"> Two studies further excluded patients if palatal complete concentric collapse was observed during drug-induced sleep endoscopy (DISE) because absence of palatal complete concentric collapse during DISE has been shown to predict the therapeutic success of HNS.</citation_analysis><citation_analysis attribute="positive"><xref rid="b34-nss-6-137" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b79-nss-6-137" ref-type="bibr">79</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">In all five studies, AHI was decreased by ≥50% and the oxygen desaturation index significantly improved at various time points (3, 6, or 12 months) after implantation.</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="neither"> The apnea index and hypopnea index each were significantly decreased.</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b78-nss-6-137" ref-type="bibr">78</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="positive"> There were significant improvements in symptoms as quantified by improvements in daily functioning, excessive daytime sleepiness, mood, sleep quality, and quality of life.</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b78-nss-6-137" ref-type="bibr">78</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="positive"> In two trials, there were increases in sleep efficiency and positive changes in sleep architecture, while two other studies showed no differences.</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b78-nss-6-137" ref-type="bibr">78</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b81-nss-6-137" ref-type="bibr">81</xref></citation_analysis><citation_analysis attribute="neither"> When OSA patients were taken off HNS therapy for at least 5 days, the AHI and oxygen desaturation index returned back to levels prior to implantation.</citation_analysis><citation_analysis attribute="positive"><xref rid="b79-nss-6-137" ref-type="bibr">79</xref></citation_analysis><citation_analysis attribute="positive"> However, there is evidence that one-night off-stimulation resulted in a similar AHI and oxygen desaturation index as the previous on-stimulation night, suggesting that HNS therapy could have residual effects lasting for at least one night.</citation_analysis><citation_analysis attribute="positive"><xref rid="b82-nss-6-137" ref-type="bibr">82</xref></citation_analysis><citation_analysis attribute="neither"> This insight suggests the intriguing possibility of alternate night treatment.</citation_analysis><citation_analysis attribute="positive"><xref rid="b82-nss-6-137" ref-type="bibr">82</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">HNS therapy is initially invasive, requiring surgery, and adverse events related to the implantation procedure or stimulation therapy have been reported. A majority of participants reported minor adverse procedural-related events (eg, numbness/pain/swelling/infection at incision site, temporary tongue weakness) that resolved with time, pain medication, and/or antibiotic treatment, or minor adverse therapy-related events (eg, tongue abrasions cause by tongue movement over teeth, discomfort associated with stimulation) that resolved after acclimation.</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b78-nss-6-137" ref-type="bibr">78</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b81-nss-6-137" ref-type="bibr">81</xref></citation_analysis><citation_analysis attribute="neither"> Serious adverse events happen infrequently and initially after implantation, and involve serious infection at the incision site requiring device removal or a subsequent surgical procedure to reposition/replace the electrode cuff or to repair malfunctioning equipment.</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b78-nss-6-137" ref-type="bibr">78</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b81-nss-6-137" ref-type="bibr">81</xref></citation_analysis><citation_analysis attribute="positive"> There was also a very small percentage of participants who had HNS devices removed due to lack of objective and subjective effectiveness. The rate of system-related or procedural-related serious adverse events was between 2% and 29% after implantation.</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Phenotyping of upper airway collapse can increase the probability of HNS success. The studies above did exclude OSA patients who had pronounced upper airway abnormalities, like enlarged tonsils or a modified Mallampati score of IV, which would prevent the success of HNS.</citation_analysis><citation_analysis attribute="positive"><xref rid="b77-nss-6-137" ref-type="bibr">77</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b79-nss-6-137" ref-type="bibr">79</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b81-nss-6-137" ref-type="bibr">81</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, phenotyping for absence of palatal complete concentric collapse during DISE improved the success of HNS.</citation_analysis><citation_analysis attribute="positive"><xref rid="b79-nss-6-137" ref-type="bibr">79</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b80-nss-6-137" ref-type="bibr">80</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b83-nss-6-137" ref-type="bibr">83</xref></citation_analysis><citation_analysis attribute="positive"> However, the lack of uniformity in sedation methods during DISE, which carries its own risks, and the lack of an established consensus on DISE scoring systems needs to be addressed before DISE can be widely used to phenotype OSA patients for HNS.</citation_analysis><citation_analysis attribute="positive"><xref rid="b83-nss-6-137" ref-type="bibr">83</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">In view of mounting evidence for significant reductions in AHI and oxygen desaturation index, and the relatively low incidence of serious adverse events, HNS appears to be a promising alternative therapy for OSA patients with BMI &lt;40 who cannot tolerate or refuse to adhere to CPAP. However, larger-scale clinical studies are needed to assess the long-term safety of HNS. In addition, it will be important to assess the efficacy and safety of HNS in subjects with more severe OSA, including comorbidities, as well as in individuals with BMI &gt;40. A recent update from the Wisconsin Cohort Study has shown an increased prevalence in OSA that is correlated with an increase in BMI.</citation_analysis><citation_analysis attribute="positive"><xref rid="b84-nss-6-137" ref-type="bibr">84</xref></citation_analysis><citation_analysis attribute="neither"> A growing number of individuals with OSA remain at a BMI &gt;40, which may limit the use of HNS as a general therapeutic alternative in OSA.</citation_analysis></p>
    </sec>
    <sec>
      <title>Drug treatment</title>
      <p><citation_analysis attribute="neither">Oral drugs for treating OSA have focused on five strategies, ie, increasing ventilatory drive (eg, progestagens, theophylline, acetazolamide), increasing upper airway tone (eg, serotonergics, cholinergics), decreasing rapid eye movement sleep (eg, antidepressants, clonidine), increasing arousal threshold (eg, eszopiclone), and/or increasing the cross-sectional area or reducing the surface tension of the upper airway through topical therapy (eg, fluticasone, lubricant).</citation_analysis><citation_analysis attribute="positive"><xref rid="b85-nss-6-137" ref-type="bibr">85</xref></citation_analysis><citation_analysis attribute="positive"> A recent Cochrane review assessed three decades of clinical trials of various drugs targeting these strategies and concluded that “some of the drugs may be helpful; however, their tolerability needs to be considered in long-term trials”.</citation_analysis><citation_analysis attribute="positive"><xref rid="b85-nss-6-137" ref-type="bibr">85</xref></citation_analysis><citation_analysis attribute="neither"> The focus here is to present recent and innovative drug treatments for OSA.</citation_analysis></p>
      <p><citation_analysis attribute="neither">A recent and novel approach towards increasing upper airway tone to alleviate OSA has been the use of cannabinoids. Dronabinol is a nonselective cannabinoid type 1 (CB</citation_analysis><citation_analysis attribute="positive"><sub>1</sub></citation_analysis><citation_analysis attribute="neither">) and type 2 (CB</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="negative">) receptor agonist used historically to treat anorexia/cachexia associated with acquired immunodeficiency syndrome and to control chemotherapy-induced nausea and vomiting. At doses of 2.5–10 mg per day, dronabinol significantly reduced AHI and improved subjective sleepiness in 17 adults with moderate to severe OSA, in a single-blind dose-escalation proof-of-concept clinical trial.</citation_analysis><citation_analysis attribute="positive"><xref rid="b86-nss-6-137" ref-type="bibr">86</xref></citation_analysis><citation_analysis attribute="neither"> However, there were no changes in oxygen desaturation index, and sleep efficiency and arousal index showed improvements only during the first half of the night at the highest dose.</citation_analysis><citation_analysis attribute="positive"><xref rid="b86-nss-6-137" ref-type="bibr">86</xref></citation_analysis><citation_analysis attribute="positive"> A more recent secondary analysis of this study demonstrated a shift in the sleep electroencephalogram toward lower frequencies and improved ultradian cycling that was predictive of improved alertness.</citation_analysis><citation_analysis attribute="positive"><xref rid="b87-nss-6-137" ref-type="bibr">87</xref></citation_analysis><citation_analysis attribute="positive"> The improvement in AHI was unlikely due to any respiratory stimulant effect because animal studies have shown a decreased respiratory rate across all sleep/wake states after treatment with dronabinol.</citation_analysis><citation_analysis attribute="positive"><xref rid="b88-nss-6-137" ref-type="bibr">88</xref></citation_analysis><citation_analysis attribute="positive"> The authors attributed the decrease in AHI to increased upper airway tone and observed a significant improvement in supine AHI.</citation_analysis><citation_analysis attribute="positive"><xref rid="b86-nss-6-137" ref-type="bibr">86</xref></citation_analysis><citation_analysis attribute="neither"> This may reflect inhibition of afferent vagal nerve activity, leading to disinhibition of upper airway motor neurons. A recent report showing increased phasic activation of genioglossi, and attenuated serotonin-induced apnea in rats subjected to local nodose ganglion injections of dronabinol supports this interpretation.</citation_analysis><citation_analysis attribute="positive"><xref rid="b89-nss-6-137" ref-type="bibr">89</xref></citation_analysis><citation_analysis attribute="positive"> There were no serious adverse events associated with daily oral dronabinol. Common minor adverse events included evening somnolence (after drug administration and before lights out) and increased appetite. Although weight gain was not observed during this 3-week treatment period, this will need to be confirmed by longer-term trials with cannabinoids.</citation_analysis><citation_analysis attribute="positive"><xref rid="b86-nss-6-137" ref-type="bibr">86</xref></citation_analysis><citation_analysis attribute="neither"> Larger-scale, randomized controlled long-term studies will be needed to establish the efficacy and safety of cannabinoids in the treatment of OSA.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Another new therapeutic strategy to treat OSA is to pharmaceutically modify loop gain.</citation_analysis><citation_analysis attribute="positive"><xref rid="b5-nss-6-137" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="positive"> Two studies have shown that some patients with OSA have high loop gain, and therefore, unstable ventilatory systems prone to apneas.</citation_analysis><citation_analysis attribute="positive"><xref rid="b90-nss-6-137" ref-type="bibr">90</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b91-nss-6-137" ref-type="bibr">91</xref></citation_analysis><citation_analysis attribute="neither"> In a recent non-blinded study, patients taking acetazolamide 500 mg twice daily for 7 days exhibited significantly decreased loop gain and AHI when compared with baseline levels.</citation_analysis><citation_analysis attribute="positive"><xref rid="b92-nss-6-137" ref-type="bibr">92</xref></citation_analysis><citation_analysis attribute="positive"> This improvement in ventilatory stability was attributed to a reduction in the magnitude of the ventilatory response to arousal. The ventilatory system was desensitized to disturbances contributing to ventilatory instability.</citation_analysis><citation_analysis attribute="positive"><xref rid="b92-nss-6-137" ref-type="bibr">92</xref></citation_analysis><citation_analysis attribute="neither"> Unfortunately, long-term usage of acetazolamide is poorly tolerated and might not be a viable treatment option.</citation_analysis><citation_analysis attribute="positive"><xref rid="b5-nss-6-137" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="positive"> Randomized, double-blind, long-term studies are needed to verify the feasibility of using acetazolamide in the treatment of OSA.</citation_analysis></p>
      <p><citation_analysis attribute="neither">OSA has been linked to gastroesophageal reflux disease (GERD), and several studies suggest that treatment of GERD may decrease AHI and daytime sleepiness.</citation_analysis><citation_analysis attribute="positive"><xref rid="b93-nss-6-137" ref-type="bibr">93</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b95-nss-6-137" ref-type="bibr">95</xref></citation_analysis><citation_analysis attribute="positive"> However, these studies recruited individuals primarily for GERD. A recent study consecutively enrolled patients with OSA and investigated the effects of a proton pump inhibitor, lansoprazole, on OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="b96-nss-6-137" ref-type="bibr">96</xref></citation_analysis><citation_analysis attribute="positive"> Ninety-one percent of participants had pathological reflux episodes, and 22% of participants had at least 50% of apneas preceded by a reflux event during polysomnography. Three months of twice-daily lansoprazole decreased AHI, but there were no changes in oxygen desaturation index or sleep efficiency. Proton pump inhibitors are well tolerated, with only weak observational associations between proton pump inhibitor therapy and fractures, pneumonia, mortality, and nutritional deficiencies.</citation_analysis><citation_analysis attribute="positive"><xref rid="b97-nss-6-137" ref-type="bibr">97</xref></citation_analysis><citation_analysis attribute="neither"> Evaluation of GERD has the potential to become standard practice during OSA diagnosis.</citation_analysis></p>
      <p><citation_analysis attribute="neither">The drug therapies listed above have potential in treating OSA. However, the long-term tolerability and efficacy of these drugs remain to be demonstrated. Further basic research needs to be conducted to better elucidate the neurobiological mechanisms underlying OSA; bringing fresh insights to suggest new (or to modify previous) treatment strategies in OSA. As progress is made in this area, the hope for safe and effective pharmacotherapies in OSA may become a reality.</citation_analysis></p>
    </sec>
    <sec>
      <title>Recommendations and conclusion</title>
      <p><citation_analysis attribute="positive">Few novel treatments have emerged that have proven as efficacious as CPAP treatment, especially for more severe disease. However, the modest level of treatment adherence makes CPAP less effective, underscoring the need for more innovative interventions. For the new approaches that have emerged, few have been robustly evaluated in randomized clinical trials and those that have had small sample sizes and limited outcomes. There is no universal definition of treatment success to guide determination of the efficacy of innovative treatments. However, outcomes that might be included to demonstrate treatment effectiveness would be adequate titration (CPAP and oral appliance), improved oxygenation, reduction in sleepiness (measured by the Epworth Sleepiness Scale), improved daily functioning (measured by the Functional Outcomes of Sleep Questionnaire), enhanced neurobehavior (metrics of sustained attention measured with the Psychomotor Vigilance Task), and improved mood (measured with a mood instrument such as the Profile of Mood States). In addition to providing the definition and outcomes of treatment success, larger clinical trials of novel interventions are needed with an evaluation of long-term treatment outcomes that reflect the variety of impairments associated with OSA.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><citation_analysis attribute="positive">
          </citation_analysis><citation_analysis attribute="positive"><bold>Disclosure</bold></citation_analysis><citation_analysis attribute="positive">
        </citation_analysis></p>
        <p><citation_analysis attribute="neither">Dr Carley owns common shares of Cortex Pharmaceuticals, a publicly traded company working to develop pharmacological treatments for sleep apnea syndrome and other breathing disorders, and is an inventor on patents related to pharmacological treatments for sleep apnea syndrome. The other authors report no conflicts of interest in this work.</citation_analysis></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-nss-6-137">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Peppard</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Gottlieb</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology of obstructive sleep apnea: a population health perspective</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2002</year>
          <volume>165</volume>
          <issue>9</issue>
          <fpage>1217</fpage>
          <lpage>1239</lpage>
          <pub-id pub-id-type="pmid">11991871</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-nss-6-137">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al Ghanim</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Comondore</surname>
              <given-names>VR</given-names>
            </name>
            <name>
              <surname>Fleetham</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Marra</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Ayas</surname>
              <given-names>NT</given-names>
            </name>
          </person-group>
          <article-title>The economic impact of obstructive sleep apnea</article-title>
          <source>Lung</source>
          <year>2008</year>
          <volume>186</volume>
          <issue>1</issue>
          <fpage>7</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">18066623</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-nss-6-137">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sassani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Findley</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Kryger</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome</article-title>
          <source>Sleep</source>
          <year>2004</year>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>453</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="pmid">15164898</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-nss-6-137">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weaver</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Maislin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dinges</surname>
              <given-names>DF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning</article-title>
          <source>Sleep</source>
          <year>2007</year>
          <volume>30</volume>
          <issue>6</issue>
          <fpage>711</fpage>
          <lpage>719</lpage>
          <pub-id pub-id-type="pmid">17580592</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-nss-6-137">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burgess</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>New insights from the measurement of loop gain in obstructive sleep apnoea</article-title>
          <source>J Physiol</source>
          <year>2012</year>
          <volume>590</volume>
          <issue>Pt 8</issue>
          <fpage>1781</fpage>
          <lpage>1782</lpage>
          <pub-id pub-id-type="pmid">22532646</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-nss-6-137">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dellweg</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kerl</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hoehn</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wenzel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koehler</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea)</article-title>
          <source>Sleep</source>
          <year>2013</year>
          <volume>36</volume>
          <issue>8</issue>
          <fpage>1163</fpage>
          <lpage>1171</lpage>
          <pub-id pub-id-type="pmid">23904676</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-nss-6-137">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aurora</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Chowdhuri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ramar</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses</article-title>
          <source>Sleep</source>
          <year>2012</year>
          <volume>35</volume>
          <issue>1</issue>
          <fpage>17</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">22215916</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-nss-6-137">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>McSharry</surname>
              <given-names>DG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis</article-title>
          <source>Chest</source>
          <year>2012</year>
          <volume>142</volume>
          <issue>5</issue>
          <fpage>1211</fpage>
          <lpage>1221</lpage>
          <pub-id pub-id-type="pmid">22722232</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-nss-6-137">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wimms</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Benjafield</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>Assessment of the impact on compliance of a new CPAP system in obstructive sleep apnea</article-title>
          <source>Sleep Breath</source>
          <year>2013</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>69</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="pmid">22286779</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-nss-6-137">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dungan</surname>
              <given-names>GC</given-names>
              <suffix>2nd</suffix>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Hoyos</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Yee</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Grunstein</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>A randomized crossover trial of the effect of a novel method of pressure control (SensAwake) in automatic continuous positive airway pressure therapy to treat sleep disordered breathing</article-title>
          <source>J Clin Sleep Med</source>
          <year>2011</year>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>261</fpage>
          <lpage>267</lpage>
          <pub-id pub-id-type="pmid">21677895</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-nss-6-137">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wozniak</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Lasserson</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2014</year>
          <volume>1</volume>
          <fpage>CD007736</fpage>
          <pub-id pub-id-type="pmid">24399660</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-nss-6-137">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bartlett</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increasing adherence to obstructive sleep apnea treatment with a group social cognitive therapy treatment intervention: a randomized trial</article-title>
          <source>Sleep</source>
          <year>2013</year>
          <volume>36</volume>
          <issue>11</issue>
          <fpage>1647</fpage>
          <lpage>1654</lpage>
          <pub-id pub-id-type="pmid">24179297</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-nss-6-137">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deng</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Stage-matched intervention for adherence to CPAP in patients with obstructive sleep apnea: a randomized controlled trial</article-title>
          <source>Sleep Breath</source>
          <year>2013</year>
          <volume>17</volume>
          <issue>2</issue>
          <fpage>791</fpage>
          <lpage>801</lpage>
          <pub-id pub-id-type="pmid">22945541</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-nss-6-137">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sawyer</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Hanlon</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk assessment for CPAP nonadherence in adults with newly diagnosed obstructive sleep apnea: preliminary testing of the Index for Nonadherence to PAP (I-NAP)</article-title>
          <source>Sleep Breath</source>
          <month>3</month>
          <day>5</day>
          <year>2014</year>
          <comment>[Epub ahead of print.]</comment>
        </element-citation>
      </ref>
      <ref id="b15-nss-6-137">
        <label>15</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Schwab</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Gefter</surname>
              <given-names>WB</given-names>
            </name>
          </person-group>
          <article-title>Anatomical factors: insights from imaging studies</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Pack</surname>
              <given-names>AI</given-names>
            </name>
          </person-group>
          <source>Sleep Apnea: Pathogenesis, Diagnosis, and Treatment</source>
          <publisher-loc>New York, NY, USA</publisher-loc>
          <publisher-name>Marcel Dekker</publisher-name>
          <year>2002</year>
        </element-citation>
      </ref>
      <ref id="b16-nss-6-137">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morrell</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Arabi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zahn</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Badr</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Progressive retropalatal narrowing preceding obstructive apnea</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>1998</year>
          <volume>158</volume>
          <issue>6</issue>
          <fpage>1974</fpage>
          <lpage>1981</lpage>
          <pub-id pub-id-type="pmid">9847295</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-nss-6-137">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yucel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Unlu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haktanir</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Acar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fidan</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the upper airway cross-sectional area changes in different degrees of severity of obstructive sleep apnea syndrome: cephalometric and dynamic CT study</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>2005</year>
          <volume>26</volume>
          <issue>10</issue>
          <fpage>2624</fpage>
          <lpage>2629</lpage>
          <pub-id pub-id-type="pmid">16286412</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-nss-6-137">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colrain</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A pilot evaluation of a nasal expiratory resistance device for the treatment of obstructive sleep apnea</article-title>
          <source>J Clin Sleep Med</source>
          <year>2008</year>
          <volume>4</volume>
          <issue>5</issue>
          <fpage>426</fpage>
          <lpage>433</lpage>
          <pub-id pub-id-type="pmid">18853699</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-nss-6-137">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Morgenthaler</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Gay</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Novel and emerging nonpositive airway pressure therapies for sleep apnea</article-title>
          <source>Chest</source>
          <year>2013</year>
          <volume>144</volume>
          <issue>6</issue>
          <fpage>1946</fpage>
          <lpage>1952</lpage>
          <pub-id pub-id-type="pmid">24297128</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-nss-6-137">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenthal</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Massie</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Dolan</surname>
              <given-names>DC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A multicenter, prospective study of a novel nasal EPAP device in the treatment of obstructive sleep apnea: efficacy and 30-day adherence</article-title>
          <source>J Clin Sleep Med</source>
          <year>2009</year>
          <volume>5</volume>
          <issue>6</issue>
          <fpage>532</fpage>
          <lpage>537</lpage>
          <pub-id pub-id-type="pmid">20465019</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-nss-6-137">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berry</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Kryger</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Massie</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial</article-title>
          <source>Sleep</source>
          <year>2011</year>
          <volume>34</volume>
          <issue>4</issue>
          <fpage>479</fpage>
          <lpage>485</lpage>
          <pub-id pub-id-type="pmid">21461326</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-nss-6-137">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kryger</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Berry</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Massie</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Long-term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apnea (OSA)</article-title>
          <source>J Clin Sleep Med</source>
          <year>2011</year>
          <volume>7</volume>
          <issue>5</issue>
          <fpage>449B</fpage>
          <lpage>453B</lpage>
          <pub-id pub-id-type="pmid">22003339</pub-id>
        </element-citation>
      </ref>
      <ref id="b23-nss-6-137">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patel</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Masdeu</surname>
              <given-names>MJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea</article-title>
          <source>J Clin Sleep Med</source>
          <year>2011</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>13</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">21344051</pub-id>
        </element-citation>
      </ref>
      <ref id="b24-nss-6-137">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walsh</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Forst</surname>
              <given-names>EH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A convenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients non-adherent with continuous positive airway pressure</article-title>
          <source>Sleep Med</source>
          <year>2011</year>
          <volume>12</volume>
          <issue>2</issue>
          <fpage>147</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="pmid">21256800</pub-id>
        </element-citation>
      </ref>
      <ref id="b25-nss-6-137">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sawyer</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Gooneratne</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Marcus</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Ofer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>TE</given-names>
            </name>
          </person-group>
          <article-title>A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions</article-title>
          <source>Sleep Med Rev</source>
          <year>2011</year>
          <volume>15</volume>
          <issue>6</issue>
          <fpage>343</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="pmid">21652236</pub-id>
        </element-citation>
      </ref>
      <ref id="b26-nss-6-137">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farid-Moayer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A feasibility evaluation of oral pressure therapy for the treatment of obstructive sleep apnea</article-title>
          <source>Ther Adv Respir Dis</source>
          <year>2013</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>3</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">23184709</pub-id>
        </element-citation>
      </ref>
      <ref id="b27-nss-6-137">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colrain</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>LC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea</article-title>
          <source>Sleep Med</source>
          <year>2013</year>
          <volume>14</volume>
          <issue>9</issue>
          <fpage>830</fpage>
          <lpage>837</lpage>
          <pub-id pub-id-type="pmid">23871259</pub-id>
        </element-citation>
      </ref>
      <ref id="b28-nss-6-137">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deane</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Cistulli</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>AT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparison of mandibular advancement splint and tongue stabilizing device in obstructive sleep apnea: a randomized controlled trial</article-title>
          <source>Sleep</source>
          <year>2009</year>
          <volume>32</volume>
          <issue>5</issue>
          <fpage>648</fpage>
          <lpage>653</lpage>
          <pub-id pub-id-type="pmid">19480232</pub-id>
        </element-citation>
      </ref>
      <ref id="b29-nss-6-137">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Keropian</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pillar</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Effects of the full breath solution appliance for the treatment of obstructive sleep apnea: a preliminary study</article-title>
          <source>Cranio</source>
          <year>2009</year>
          <volume>27</volume>
          <issue>2</issue>
          <fpage>109</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="pmid">19455922</pub-id>
        </element-citation>
      </ref>
      <ref id="b30-nss-6-137">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dort</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Remmers</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A combination appliance for obstructive sleep apnea: the effectiveness of mandibular advancement and tongue retention</article-title>
          <source>J Clin Sleep Med</source>
          <year>2012</year>
          <volume>8</volume>
          <issue>3</issue>
          <fpage>265</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">22701383</pub-id>
        </element-citation>
      </ref>
      <ref id="b31-nss-6-137">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ngiam</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kyung</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Microimplant-based mandibular advancement therapy for the treatment of snoring and obstructive sleep apnea: a prospective study</article-title>
          <source>Angle Orthod</source>
          <year>2012</year>
          <volume>82</volume>
          <issue>6</issue>
          <fpage>978</fpage>
          <lpage>984</lpage>
          <pub-id pub-id-type="pmid">22594775</pub-id>
        </element-citation>
      </ref>
      <ref id="b32-nss-6-137">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Almeida</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Mulgrew</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ayas</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mandibular advancement splint as short-term alternative treatment in patients with obstructive sleep apnea already effectively treated with continuous positive airway pressure</article-title>
          <source>J Clin Sleep Med</source>
          <year>2013</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>319</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">23585745</pub-id>
        </element-citation>
      </ref>
      <ref id="b33-nss-6-137">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dieltjens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vanderveken</surname>
              <given-names>OM</given-names>
            </name>
            <name>
              <surname>Heyning</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Braem</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Current opinions and clinical practice in the titration of oral appliances in the treatment of sleep-disordered breathing</article-title>
          <source>Sleep Med Rev</source>
          <year>2012</year>
          <volume>16</volume>
          <issue>2</issue>
          <fpage>177</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="pmid">22033170</pub-id>
        </element-citation>
      </ref>
      <ref id="b34-nss-6-137">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanderveken</surname>
              <given-names>OM</given-names>
            </name>
            <name>
              <surname>Dieltjens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wouters</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing</article-title>
          <source>Thorax</source>
          <year>2013</year>
          <volume>68</volume>
          <issue>1</issue>
          <fpage>91</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">22993169</pub-id>
        </element-citation>
      </ref>
      <ref id="b35-nss-6-137">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dieltjens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Braem</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Vroegop</surname>
              <given-names>AV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Objectively measured vs self-reported compliance during oral appliance therapy for sleep-disordered breathing</article-title>
          <source>Chest</source>
          <year>2013</year>
          <volume>144</volume>
          <issue>5</issue>
          <fpage>1495</fpage>
          <lpage>1502</lpage>
          <pub-id pub-id-type="pmid">23928873</pub-id>
        </element-citation>
      </ref>
      <ref id="b36-nss-6-137">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Verrett</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of a novel device for measuring patient compliance with oral appliances in the treatment of obstructive sleep apnea</article-title>
          <source>J Prosthodont</source>
          <year>2014</year>
          <volume>23</volume>
          <issue>1</issue>
          <fpage>31</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="pmid">23889695</pub-id>
        </element-citation>
      </ref>
      <ref id="b37-nss-6-137">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>Updates in oral appliance therapy for snoring and obstructive sleep apnea</article-title>
          <source>Sleep Breath</source>
          <year>2013</year>
          <volume>17</volume>
          <issue>2</issue>
          <fpage>473</fpage>
          <lpage>486</lpage>
          <pub-id pub-id-type="pmid">22562263</pub-id>
        </element-citation>
      </ref>
      <ref id="b38-nss-6-137">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsuiki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Isono</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Oropharyngeal crowding and obesity as predictors of oral appliance treatment response to moderate obstructive sleep apnea</article-title>
          <source>Chest</source>
          <year>2013</year>
          <volume>144</volume>
          <issue>2</issue>
          <fpage>558</fpage>
          <lpage>563</lpage>
          <pub-id pub-id-type="pmid">23493981</pub-id>
        </element-citation>
      </ref>
      <ref id="b39-nss-6-137">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>YW</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>YF</given-names>
            </name>
          </person-group>
          <article-title>Craniofacial morphologic predictors of oral appliance outcomes in patients with obstructive sleep apnea</article-title>
          <source>J Am Dent Assoc</source>
          <year>2012</year>
          <volume>143</volume>
          <issue>11</issue>
          <fpage>1209</fpage>
          <lpage>1217</lpage>
          <pub-id pub-id-type="pmid">23115150</pub-id>
        </element-citation>
      </ref>
      <ref id="b40-nss-6-137">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Darendeliler</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Petocz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cistulli</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Cephalometry and prediction of oral appliance treatment outcome</article-title>
          <source>Sleep Breath</source>
          <year>2012</year>
          <volume>16</volume>
          <issue>1</issue>
          <fpage>47</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">21424283</pub-id>
        </element-citation>
      </ref>
      <ref id="b41-nss-6-137">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choudhury</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Padmanabhan</surname>
              <given-names>TV</given-names>
            </name>
          </person-group>
          <article-title>A preliminary report on the effect of a mandibular advancement device on obstructive sleep apnea using magnetic resonance imaging and polysomnography</article-title>
          <source>Int J Prosthodont</source>
          <year>2012</year>
          <volume>25</volume>
          <issue>6</issue>
          <fpage>613</fpage>
          <lpage>618</lpage>
          <pub-id pub-id-type="pmid">23101041</pub-id>
        </element-citation>
      </ref>
      <ref id="b42-nss-6-137">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furuhashi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shiomi</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effective three-dimensional evaluation analysis of upper airway form during oral appliance therapy in patients with obstructive sleep apnoea</article-title>
          <source>J Oral Rehabil</source>
          <year>2013</year>
          <volume>40</volume>
          <issue>8</issue>
          <fpage>582</fpage>
          <lpage>589</lpage>
          <pub-id pub-id-type="pmid">23692649</pub-id>
        </element-citation>
      </ref>
      <ref id="b43-nss-6-137">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alsufyani</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Al-Saleh</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Major</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>CBCT assessment of upper airway changes and treatment outcomes of obstructive sleep apnoea: a systematic review</article-title>
          <source>Sleep Breath</source>
          <year>2013</year>
          <volume>17</volume>
          <issue>3</issue>
          <fpage>911</fpage>
          <lpage>923</lpage>
          <pub-id pub-id-type="pmid">23344828</pub-id>
        </element-citation>
      </ref>
      <ref id="b44-nss-6-137">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Battagel</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Kotecha</surname>
              <given-names>BT</given-names>
            </name>
          </person-group>
          <article-title>Sleep nasendoscopy: a diagnostic tool for predicting treatment success with mandibular advancement splints in obstructive sleep apnoea</article-title>
          <source>Eur J Orthod</source>
          <year>2005</year>
          <volume>27</volume>
          <issue>6</issue>
          <fpage>607</fpage>
          <lpage>614</lpage>
          <pub-id pub-id-type="pmid">16049036</pub-id>
        </element-citation>
      </ref>
      <ref id="b45-nss-6-137">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sasao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nohara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Okuno</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sakai</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Videoendoscopic diagnosis for predicting the response to oral appliance therapy in severe obstructive sleep apnea</article-title>
          <source>Sleep Breath</source>
          <month>2</month>
          <day>15</day>
          <year>2014</year>
          <comment>[Epub ahead of print.]</comment>
        </element-citation>
      </ref>
      <ref id="b46-nss-6-137">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oksenberg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Silverberg</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Arons</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Radwan</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data</article-title>
          <source>Chest</source>
          <year>1997</year>
          <volume>112</volume>
          <issue>3</issue>
          <fpage>629</fpage>
          <lpage>639</lpage>
          <pub-id pub-id-type="pmid">9315794</pub-id>
        </element-citation>
      </ref>
      <ref id="b47-nss-6-137">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cartwright</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Effect of sleep position on sleep apnea severity</article-title>
          <source>Sleep</source>
          <year>1984</year>
          <volume>7</volume>
          <issue>2</issue>
          <fpage>110</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="pmid">6740055</pub-id>
        </element-citation>
      </ref>
      <ref id="b48-nss-6-137">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ravesloot</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van Maanen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dun</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>de Vries</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>The undervalued potential of positional therapy in position-dependent snoring and obstructive sleep apnea-a review of the literature</article-title>
          <source>Sleep Breath</source>
          <year>2013</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>39</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">22441662</pub-id>
        </element-citation>
      </ref>
      <ref id="b49-nss-6-137">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bignold</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Mercer</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Antic</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>McEvoy</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Catcheside</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Accurate position monitoring and improved supine-dependent obstructive sleep apnea with a new position recording and supine avoidance device</article-title>
          <source>J Clin Sleep Med</source>
          <year>2011</year>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>376</fpage>
          <lpage>383</lpage>
          <pub-id pub-id-type="pmid">21897774</pub-id>
        </element-citation>
      </ref>
      <ref id="b50-nss-6-137">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Maanen</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Meester</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Dun</surname>
              <given-names>LN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The sleep position trainer: a new treatment for positional obstructive sleep apnoea</article-title>
          <source>Sleep Breath</source>
          <year>2013</year>
          <volume>17</volume>
          <issue>2</issue>
          <fpage>771</fpage>
          <lpage>779</lpage>
          <pub-id pub-id-type="pmid">22927107</pub-id>
        </element-citation>
      </ref>
      <ref id="b51-nss-6-137">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ibrahim</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Joseph</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Staging of obstructive sleep apnea/hypopnea syndrome: a guide to appropriate treatment</article-title>
          <source>Laryngoscope</source>
          <year>2004</year>
          <volume>114</volume>
          <issue>3</issue>
          <fpage>454</fpage>
          <lpage>459</lpage>
          <pub-id pub-id-type="pmid">15091218</pub-id>
        </element-citation>
      </ref>
      <ref id="b52-nss-6-137">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aurora</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Casey</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Kristo</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Practice parameters for the surgical modifications of the upper airway for obstructive sleep apnea in adults</article-title>
          <source>Sleep</source>
          <year>2010</year>
          <volume>33</volume>
          <issue>10</issue>
          <fpage>1408</fpage>
          <lpage>1413</lpage>
          <pub-id pub-id-type="pmid">21061864</pub-id>
        </element-citation>
      </ref>
      <ref id="b53-nss-6-137">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caples</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Rowley</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Prinsell</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis</article-title>
          <source>Sleep</source>
          <year>2010</year>
          <volume>33</volume>
          <issue>10</issue>
          <fpage>1396</fpage>
          <lpage>1407</lpage>
          <pub-id pub-id-type="pmid">21061863</pub-id>
        </element-citation>
      </ref>
      <ref id="b54-nss-6-137">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Gurpinar</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>The efficacy of multilevel surgery of the upper airway in adults with obstructive sleep apnea/hypopnea syndrome</article-title>
          <source>Laryngoscope</source>
          <year>2008</year>
          <volume>118</volume>
          <issue>5</issue>
          <fpage>902</fpage>
          <lpage>908</lpage>
          <pub-id pub-id-type="pmid">18300704</pub-id>
        </element-citation>
      </ref>
      <ref id="b55-nss-6-137">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Handler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hamans</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Mickelson</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Tongue suspension: an evidence-based review and comparison to hypopharyngeal surgery for OSA</article-title>
          <source>Laryngoscope</source>
          <year>2014</year>
          <volume>124</volume>
          <issue>1</issue>
          <fpage>329</fpage>
          <lpage>336</lpage>
          <pub-id pub-id-type="pmid">23729234</pub-id>
        </element-citation>
      </ref>
      <ref id="b56-nss-6-137">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gunawardena</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>MacKay</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Submucosal lingualplasty for adult obstructive sleep apnea</article-title>
          <source>Otolaryngol Head Neck Surg</source>
          <year>2013</year>
          <volume>148</volume>
          <issue>1</issue>
          <fpage>157</fpage>
          <lpage>165</lpage>
          <pub-id pub-id-type="pmid">23014996</pub-id>
        </element-citation>
      </ref>
      <ref id="b57-nss-6-137">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blumen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Coquille</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chabolle</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Lingual tonsil reduction in OSA: transcervical radiofrequency ablation</article-title>
          <source>Eur Ann Otorhinolaryngol Head Neck Dis</source>
          <year>2012</year>
          <volume>129</volume>
          <issue>6</issue>
          <fpage>339</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="pmid">23073498</pub-id>
        </element-citation>
      </ref>
      <ref id="b58-nss-6-137">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shine</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Transpalatal advancement pharyngoplasty for obstructive sleep apnea syndrome: results and analysis of failures</article-title>
          <source>Arch Otolaryngol Head Neck Surg</source>
          <year>2009</year>
          <volume>135</volume>
          <issue>5</issue>
          <fpage>434</fpage>
          <lpage>438</lpage>
          <pub-id pub-id-type="pmid">19451461</pub-id>
        </element-citation>
      </ref>
      <ref id="b59-nss-6-137">
        <label>59</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacKay</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Carney</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Woods</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modified uvulopalatopharyngoplasty and coblation channeling of the tongue for obstructive sleep apnea: a multi-centre Australian trial</article-title>
          <source>J Clin Sleep Med</source>
          <year>2013</year>
          <volume>9</volume>
          <issue>2</issue>
          <fpage>117</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="pmid">23372463</pub-id>
        </element-citation>
      </ref>
      <ref id="b60-nss-6-137">
        <label>60</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Rowley</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Badr</surname>
              <given-names>MS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transoral robotic surgery for treatment of obstructive sleep apnea-hypopnea syndrome</article-title>
          <source>Laryngoscope</source>
          <year>2013</year>
          <volume>123</volume>
          <issue>7</issue>
          <fpage>1811</fpage>
          <lpage>1816</lpage>
          <pub-id pub-id-type="pmid">23553290</pub-id>
        </element-citation>
      </ref>
      <ref id="b61-nss-6-137">
        <label>61</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsieh</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YR</given-names>
            </name>
          </person-group>
          <article-title>Changes in the calibre of the upper airway and the surrounding structures after maxillomandibular advancement for obstructive sleep apnoea</article-title>
          <source>Br J Oral Maxillofac Surg</source>
          <year>2014</year>
          <volume>52</volume>
          <issue>5</issue>
          <fpage>445</fpage>
          <lpage>451</lpage>
          <pub-id pub-id-type="pmid">24629456</pub-id>
        </element-citation>
      </ref>
      <ref id="b62-nss-6-137">
        <label>62</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barrera</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Virtual surgical planning improves surgical outcome measures in obstructive sleep apnea surgery</article-title>
          <source>Laryngoscope</source>
          <year>2014</year>
          <volume>124</volume>
          <issue>5</issue>
          <fpage>1259</fpage>
          <lpage>1266</lpage>
          <pub-id pub-id-type="pmid">24357526</pub-id>
        </element-citation>
      </ref>
      <ref id="b63-nss-6-137">
        <label>63</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Camacho</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Certal</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Brietzke</surname>
              <given-names>SE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tracheostomy as treatment for adult obstructive sleep apnea: a systematic review and meta-analysis</article-title>
          <source>Laryngoscope</source>
          <year>2014</year>
          <volume>124</volume>
          <issue>3</issue>
          <fpage>803</fpage>
          <lpage>811</lpage>
          <pub-id pub-id-type="pmid">24549987</pub-id>
        </element-citation>
      </ref>
      <ref id="b64-nss-6-137">
        <label>64</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weaver</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Woodson</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Yueh</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Studying Life Effects and Effectiveness of Palatopharyngoplasty (SLEEP) study: subjective outcomes of isolated uvulopalatopharyngoplasty</article-title>
          <source>Otolaryngol Head Neck Surg</source>
          <year>2011</year>
          <volume>144</volume>
          <issue>4</issue>
          <fpage>623</fpage>
          <lpage>631</lpage>
          <pub-id pub-id-type="pmid">21493246</pub-id>
        </element-citation>
      </ref>
      <ref id="b65-nss-6-137">
        <label>65</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haraldsson</surname>
              <given-names>PO</given-names>
            </name>
            <name>
              <surname>Carenfelt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lysdahl</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tornros</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Long-term effect of uvulopalatopharyngoplasty on driving performance</article-title>
          <source>Arch Otolaryngol Head Neck Surg</source>
          <year>1995</year>
          <volume>121</volume>
          <issue>1</issue>
          <fpage>90</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="pmid">7803027</pub-id>
        </element-citation>
      </ref>
      <ref id="b66-nss-6-137">
        <label>66</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boyd</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Walters</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Comparative effectiveness of maxillomandibular advancement and uvulopalatopharyngoplasty for the treatment of moderate to severe obstructive sleep apnea</article-title>
          <source>J Oral Maxillofac Surg</source>
          <year>2013</year>
          <volume>71</volume>
          <issue>4</issue>
          <fpage>743</fpage>
          <lpage>751</lpage>
          <pub-id pub-id-type="pmid">23219145</pub-id>
        </element-citation>
      </ref>
      <ref id="b67-nss-6-137">
        <label>67</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Remmers</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>deGroot</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Sauerland</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Anch</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Pathogenesis of upper airway occlusion during sleep</article-title>
          <source>J Appl Physiol Respir Environ Exerc Physiol</source>
          <year>1978</year>
          <volume>44</volume>
          <issue>6</issue>
          <fpage>931</fpage>
          <lpage>938</lpage>
          <pub-id pub-id-type="pmid">670014</pub-id>
        </element-citation>
      </ref>
      <ref id="b68-nss-6-137">
        <label>68</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Decker</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Haaga</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Arnold</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Atzberger</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Strohl</surname>
              <given-names>KP</given-names>
            </name>
          </person-group>
          <article-title>Functional electrical stimulation and respiration during sleep</article-title>
          <source>J Appl Physiol</source>
          <year>1993</year>
          <volume>75</volume>
          <issue>3</issue>
          <fpage>1053</fpage>
          <lpage>1061</lpage>
          <pub-id pub-id-type="pmid">8226511</pub-id>
        </element-citation>
      </ref>
      <ref id="b69-nss-6-137">
        <label>69</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edmonds</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Stanson</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Sheedy</surname>
              <given-names>PF</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Shepard</surname>
              <given-names>JW</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>The effects of transcutaneous electrical stimulation during wakefulness and sleep in patients with obstructive sleep apnea</article-title>
          <source>Am Rev Respir Dis</source>
          <year>1992</year>
          <volume>146</volume>
          <issue>4</issue>
          <fpage>1030</fpage>
          <lpage>1036</lpage>
          <pub-id pub-id-type="pmid">1416392</pub-id>
        </element-citation>
      </ref>
      <ref id="b70-nss-6-137">
        <label>70</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guilleminault</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Powell</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bowman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Stoohs</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The effect of electrical stimulation on obstructive sleep apnea syndrome</article-title>
          <source>Chest</source>
          <year>1995</year>
          <volume>107</volume>
          <issue>1</issue>
          <fpage>67</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">7813315</pub-id>
        </element-citation>
      </ref>
      <ref id="b71-nss-6-137">
        <label>71</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hida</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chonan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kikuchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takishima</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Effects of submental electrical stimulation during sleep on upper airway patency in patients with obstructive sleep apnea</article-title>
          <source>Am Rev Respir Dis</source>
          <year>1989</year>
          <volume>140</volume>
          <issue>5</issue>
          <fpage>1285</fpage>
          <lpage>1289</lpage>
          <pub-id pub-id-type="pmid">2817590</pub-id>
        </element-citation>
      </ref>
      <ref id="b72-nss-6-137">
        <label>72</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steier</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Seymour</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rafferty</surname>
              <given-names>GF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Continuous transcutaneous submental electrical stimulation in obstructive sleep apnea: a feasibility study</article-title>
          <source>Chest</source>
          <year>2011</year>
          <volume>140</volume>
          <issue>4</issue>
          <fpage>998</fpage>
          <lpage>1007</lpage>
          <pub-id pub-id-type="pmid">21454399</pub-id>
        </element-citation>
      </ref>
      <ref id="b73-nss-6-137">
        <label>73</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eisele</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Tongue neuromuscular and direct hypoglossal nerve stimulation for obstructive sleep apnea</article-title>
          <source>Otolaryngol Clin North Am</source>
          <year>2003</year>
          <volume>36</volume>
          <issue>3</issue>
          <fpage>501</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="pmid">12956097</pub-id>
        </element-citation>
      </ref>
      <ref id="b74-nss-6-137">
        <label>74</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ilomaki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Baer</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Karhuketo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Talonen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Puhakka</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Pharyngeal patency caused by stimulation of the hypoglossal nerve in anaesthesia-relaxed patients</article-title>
          <source>Acta Otolaryngol Suppl</source>
          <year>1997</year>
          <volume>529</volume>
          <fpage>210</fpage>
          <lpage>211</lpage>
          <pub-id pub-id-type="pmid">9288312</pub-id>
        </element-citation>
      </ref>
      <ref id="b75-nss-6-137">
        <label>75</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliven</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>O’Hearn</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Boudewyns</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Upper airway response to electrical stimulation of the genioglossus in obstructive sleep apnea</article-title>
          <source>J Appl Physiol</source>
          <year>2003</year>
          <volume>95</volume>
          <issue>5</issue>
          <fpage>2023</fpage>
          <lpage>2029</lpage>
          <pub-id pub-id-type="pmid">14555669</pub-id>
        </element-citation>
      </ref>
      <ref id="b76-nss-6-137">
        <label>76</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Oliven</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Electrical stimulation of the hypoglossal nerve: a potential therapy</article-title>
          <source>J Appl Physiol</source>
          <year>2014</year>
          <volume>116</volume>
          <issue>3</issue>
          <fpage>337</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="pmid">23813525</pub-id>
        </element-citation>
      </ref>
      <ref id="b77-nss-6-137">
        <label>77</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eastwood</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>JH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Treating obstructive sleep apnea with hypoglossal nerve stimulation</article-title>
          <source>Sleep</source>
          <year>2011</year>
          <volume>34</volume>
          <issue>11</issue>
          <fpage>1479</fpage>
          <lpage>1486</lpage>
          <pub-id pub-id-type="pmid">22043118</pub-id>
        </element-citation>
      </ref>
      <ref id="b78-nss-6-137">
        <label>78</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kezirian</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Goding</surname>
              <given-names>GS</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Malhotra</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hypoglossal nerve stimulation improves obstructive sleep apnea: 12-month outcomes</article-title>
          <source>J Sleep Res</source>
          <year>2014</year>
          <volume>23</volume>
          <issue>1</issue>
          <fpage>77</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">24033656</pub-id>
        </element-citation>
      </ref>
      <ref id="b79-nss-6-137">
        <label>79</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strollo</surname>
              <given-names>PJ</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Soose</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Maurer</surname>
              <given-names>JT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Upper-airway stimulation for obstructive sleep apnea</article-title>
          <source>N Engl J Med</source>
          <year>2014</year>
          <volume>370</volume>
          <issue>2</issue>
          <fpage>139</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="pmid">24401051</pub-id>
        </element-citation>
      </ref>
      <ref id="b80-nss-6-137">
        <label>80</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van de Heyning</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Badr</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Baskin</surname>
              <given-names>JZ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Implanted upper airway stimulation device for obstructive sleep apnea</article-title>
          <source>Laryngoscope</source>
          <year>2012</year>
          <volume>122</volume>
          <issue>7</issue>
          <fpage>1626</fpage>
          <lpage>1633</lpage>
          <pub-id pub-id-type="pmid">22549513</pub-id>
        </element-citation>
      </ref>
      <ref id="b81-nss-6-137">
        <label>81</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mwenge</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Rombaux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dury</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lengele</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rodenstein</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study</article-title>
          <source>Eur Respir J</source>
          <year>2013</year>
          <volume>41</volume>
          <issue>2</issue>
          <fpage>360</fpage>
          <lpage>367</lpage>
          <pub-id pub-id-type="pmid">22599356</pub-id>
        </element-citation>
      </ref>
      <ref id="b82-nss-6-137">
        <label>82</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodenstein</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rombaux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lengele</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dury</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mwenge</surname>
              <given-names>GB</given-names>
            </name>
          </person-group>
          <article-title>Residual effect of THN hypoglossal stimulation in obstructive sleep apnea: a disease-modifying therapy</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2013</year>
          <volume>187</volume>
          <issue>11</issue>
          <fpage>1276</fpage>
          <lpage>1278</lpage>
          <pub-id pub-id-type="pmid">23725628</pub-id>
        </element-citation>
      </ref>
      <ref id="b83-nss-6-137">
        <label>83</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanderveken</surname>
              <given-names>OM</given-names>
            </name>
            <name>
              <surname>Maurer</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Hohenhorst</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of drug-induced sleep endoscopy as a patient selection tool for implanted upper airway stimulation for obstructive sleep apnea</article-title>
          <source>J Clin Sleep Med</source>
          <year>2013</year>
          <volume>9</volume>
          <issue>5</issue>
          <fpage>433</fpage>
          <lpage>438</lpage>
          <pub-id pub-id-type="pmid">23674933</pub-id>
        </element-citation>
      </ref>
      <ref id="b84-nss-6-137">
        <label>84</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peppard</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Barnet</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Palta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hagen</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Hla</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Increased prevalence of sleep-disordered breathing in adults</article-title>
          <source>Am J Epidemiol</source>
          <year>2013</year>
          <volume>177</volume>
          <issue>9</issue>
          <fpage>1006</fpage>
          <lpage>1014</lpage>
          <pub-id pub-id-type="pmid">23589584</pub-id>
        </element-citation>
      </ref>
      <ref id="b85-nss-6-137">
        <label>85</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mason</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Welsh</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Drug therapy for obstructive sleep apnoea in adults</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2013</year>
          <volume>5</volume>
          <fpage>CD003002</fpage>
          <pub-id pub-id-type="pmid">23728641</pub-id>
        </element-citation>
      </ref>
      <ref id="b86-nss-6-137">
        <label>86</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prasad</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Radulovacki</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Carley</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Proof of concept trial of dronabinol in obstructive sleep apnea</article-title>
          <source>Front Psychiatry</source>
          <year>2013</year>
          <volume>4</volume>
          <fpage>1</fpage>
          <pub-id pub-id-type="pmid">23346060</pub-id>
        </element-citation>
      </ref>
      <ref id="b87-nss-6-137">
        <label>87</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farabi</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Prasad</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Carley</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome</article-title>
          <source>J Clin Sleep Med</source>
          <year>2014</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>49</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">24426820</pub-id>
        </element-citation>
      </ref>
      <ref id="b88-nss-6-137">
        <label>88</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carley</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Paviovic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Janelidze</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Radulovacki</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Functional role for cannabinoids in respiratory stability during sleep</article-title>
          <source>Sleep</source>
          <year>2002</year>
          <volume>25</volume>
          <issue>4</issue>
          <fpage>391</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="pmid">12071539</pub-id>
        </element-citation>
      </ref>
      <ref id="b89-nss-6-137">
        <label>89</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calik</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Radulovacki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Carley</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat</article-title>
          <source>Respir Physiol Neurobiol</source>
          <year>2014</year>
          <volume>190</volume>
          <fpage>20</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">24121138</pub-id>
        </element-citation>
      </ref>
      <ref id="b90-nss-6-137">
        <label>90</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eckert</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Malhotra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wellman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2013</year>
          <volume>188</volume>
          <issue>8</issue>
          <fpage>996</fpage>
          <lpage>1004</lpage>
          <pub-id pub-id-type="pmid">23721582</pub-id>
        </element-citation>
      </ref>
      <ref id="b91-nss-6-137">
        <label>91</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salloum</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rowley</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Mateika</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Chowdhuri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Omran</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Badr</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Increased propensity for central apnea in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2010</year>
          <volume>181</volume>
          <issue>2</issue>
          <fpage>189</fpage>
          <lpage>193</lpage>
          <pub-id pub-id-type="pmid">19762565</pub-id>
        </element-citation>
      </ref>
      <ref id="b92-nss-6-137">
        <label>92</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edwards</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Connolly</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Campana</surname>
              <given-names>LM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acetazolamide attenuates the ventilatory response to arousal in patients with obstructive sleep apnea</article-title>
          <source>Sleep</source>
          <year>2013</year>
          <volume>36</volume>
          <issue>2</issue>
          <fpage>281</fpage>
          <lpage>285</lpage>
          <pub-id pub-id-type="pmid">23372276</pub-id>
        </element-citation>
      </ref>
      <ref id="b93-nss-6-137">
        <label>93</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bortolotti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gentilini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Morselli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Giovannini</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Obstructive sleep apnoea is improved by a prolonged treatment of gastrooesophageal reflux with omeprazole</article-title>
          <source>Dig Liver Dis</source>
          <year>2006</year>
          <volume>38</volume>
          <issue>2</issue>
          <fpage>78</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">16256447</pub-id>
        </element-citation>
      </ref>
      <ref id="b94-nss-6-137">
        <label>94</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Senior</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schwimmer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rosenthal</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Benninger</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Gastroesophageal reflux and obstructive sleep apnea</article-title>
          <source>Laryngoscope</source>
          <year>2001</year>
          <volume>111</volume>
          <issue>12</issue>
          <fpage>2144</fpage>
          <lpage>2146</lpage>
          <pub-id pub-id-type="pmid">11802013</pub-id>
        </element-citation>
      </ref>
      <ref id="b95-nss-6-137">
        <label>95</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suurna</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Welge</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Surdulescu</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kushner</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Steward</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Randomized placebo-controlled trial of pantoprazole for daytime sleepiness in GERD and obstructive sleep disordered breathing</article-title>
          <source>Otolaryngol Head Neck Surg</source>
          <year>2008</year>
          <volume>139</volume>
          <issue>2</issue>
          <fpage>286</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="pmid">18656731</pub-id>
        </element-citation>
      </ref>
      <ref id="b96-nss-6-137">
        <label>96</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ermis</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Akyuz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Arici</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of proton pump inhibitor (PPI) treatment in obstructive sleep apnea syndrome: an esophageal impedance-pHmetry study</article-title>
          <source>Hepatogastroenterology</source>
          <year>2011</year>
          <volume>58</volume>
          <issue>110–111</issue>
          <fpage>1566</fpage>
          <lpage>1573</lpage>
          <pub-id pub-id-type="pmid">21940322</pub-id>
        </element-citation>
      </ref>
      <ref id="b97-nss-6-137">
        <label>97</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reimer</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Safety of long-term PPI therapy</article-title>
          <source>Best Pract Res Clin Gastroenterol</source>
          <year>2013</year>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>443</fpage>
          <lpage>454</lpage>
          <pub-id pub-id-type="pmid">23998981</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-nss-6-137" position="float">
      <label>Figure 1</label>
      <caption>
        <p><citation_analysis attribute="positive">Photograph of the expiratory positive airway pressure device in place.</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Reprinted from </citation_analysis><citation_analysis attribute="positive"><italic>Sleep Med</italic></citation_analysis><citation_analysis attribute="positive">, 12(2), Walsh JK, Griffin KS, Forst EH, et al. A convenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients non-adherent with continuous positive airway pressure, 147–152, Copyright © 2011, with permission from Elsevier.</citation_analysis><citation_analysis attribute="positive"><xref rid="b24-nss-6-137" ref-type="bibr">24</xref></citation_analysis></p>
      </caption>
      <graphic xlink:href="nss-6-137Fig1"/>
    </fig>
    <fig id="f2-nss-6-137" position="float">
      <label>Figure 2</label>
      <caption>
        <p><citation_analysis attribute="neither">(</citation_analysis><citation_analysis attribute="positive"><bold>A</bold></citation_analysis><citation_analysis attribute="neither">) Winx device, an oral pressure device that uses gentle suction to anteriorly and superiorly displace the tongue and the soft palate. (</citation_analysis><citation_analysis attribute="positive"><bold>B</bold></citation_analysis><citation_analysis attribute="neither">) Effect of oral pressure device on the tongue and soft palate displacement.</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Copyright © 2013. Reproduced with permission from the American College of Chest Physicians. Park JG, Morgenthaler TM, Gay PC. Novel and emerging nonpositive airway pressure therapies for sleep apnea. </citation_analysis><citation_analysis attribute="positive"><italic>Chest</italic></citation_analysis><citation_analysis attribute="neither">. 2013;144(6): 1946–1952.</citation_analysis><citation_analysis attribute="positive"><xref rid="b19-nss-6-137" ref-type="bibr">19</xref></citation_analysis></p>
      </caption>
      <graphic xlink:href="nss-6-137Fig2"/>
    </fig>
    <fig id="f3-nss-6-137" position="float">
      <label>Figure 3</label>
      <caption>
        <p><citation_analysis attribute="neither">Schematic representation of the Inspire™ I system for hypoglossal nerve stimulation in patients with obstructive sleep apnea. The stimulator (implantable pulse generator) is connected to the respiratory sensor by means of a sensor lead. A stimulation lead connects the stimulator to the half-cuff electrode around the hypoglossal nerve.</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Reprinted from </citation_analysis><citation_analysis attribute="positive"><italic>J Sleep Res</italic></citation_analysis><citation_analysis attribute="neither">, 23(1), Kezirian EJ, Goding GS Jr, Malhotra A, et al, Hypoglossal nerve stimulation improves obstructive sleep apnea: 12-month outcomes, 77–83, Copyright © 2014, with permission from Elsevier.</citation_analysis><citation_analysis attribute="positive"><xref rid="b78-nss-6-137" ref-type="bibr">78</xref></citation_analysis></p>
      </caption>
      <graphic xlink:href="nss-6-137Fig3"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
